ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI To Ask HCFA to Launch Pilot Clinical Trials Program

March 22, 1996

NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s.

December 5, 1997

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987